Applied DNA Sciences, Inc. (APDN)
APDN moved a median of -1.50% 30 minutes after news, and -0.72% by the close. How APDN actually reacts to news — the realized, point-in-time move the market made, measured across 176 labeled events over the last three years with zero look-ahead.
APDN’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | -0.53% | 39% | 173 |
| 30-min | -1.50% | 31% | 175 |
| 60-min | -1.74% | 33% | 175 |
| to close | -0.72% | 45% | 175 |
| Middle 50% of APDN reactions | -3.90% to +0.24% |
|---|---|
| Median reaction (30-min) | -1.50% |
| Measured reactions | 176 |
Half of all Applied DNA Sciences, Inc. news events land between -3.90% and +0.24% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when APDN moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to APDN's baseline. Nothing else.
Recent APDN events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Applied DNA Sciences to Begin Trading Under New Ticker ‘BNBX’ Reflecting Digital Asset Treasury Strategy | Press release | Business Wire | +1.23% | +21.64% | |
| Form 8-K APPLIED DNA SCIENCES For: Sep 30 | SEC filing · Form 8-K | SEC EDGAR | — | — | |
| Form 8-K APPLIED DNA SCIENCES For: Sep 29 | SEC filing · Form 8-K | SEC EDGAR | -3.31% | +6.91% | |
| Applied DNA Sciences Announces Private Placement of Up To $58 Million To Initiate BNB Treasury Strategy and BNB Native Yield Generation | Press release | Business Wire | +6.46% | +8.96% | |
| Form 8-K APPLIED DNA SCIENCES For: Sep 29 | SEC filing · Form 8-K | SEC EDGAR | -0.75% | -3.00% | |
| Applied DNA Abstracts Selected for Poster Presentations Showcasing LineaDNA and LineaIVT Platforms at Upcoming mRNA and CAR T Industry Conferences | Press release | ACCESS Newswire | -1.36% | +0.68% | |
| Applied DNA Reports Third Quarter Fiscal 2025 Financial Results | Press release | ACCESS Newswire | -1.72% | -3.93% | |
| Form 10-Q APPLIED DNA SCIENCES For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | -1.72% | -3.93% | |
| Form 8-K APPLIED DNA SCIENCES For: Aug 14 | SEC filing · Form 8-K | SEC EDGAR | -1.72% | -3.93% | |
| Form S-8 APPLIED DNA SCIENCES | SEC filing · Form S-8 | SEC EDGAR | -0.39% | -1.37% | |
| Applied DNA Announces New Follow-On LineaDNA Order from Global IVD Manufacturer for Use in Cancer Diagnostic Application | Press release | ACCESS Newswire | -2.57% | -7.24% | |
| Applied DNA Regains Compliance with All Nasdaq Continued Listing Requirements | Press release | ACCESS Newswire | +1.84% | +9.54% | |
| Form 8-K APPLIED DNA SCIENCES For: Jul 02 | SEC filing · Form 8-K | SEC EDGAR | -2.15% | +6.64% | |
| Applied DNA Sharpens Strategic Focus on Synthetic DNA Manufacturing for Biotherapeutics Applications, Consolidates Operations Behind LineaRx | Press release | ACCESS Newswire | -1.86% | +6.19% | |
| Form 8-K APPLIED DNA SCIENCES For: Jun 27 | SEC filing · Form 8-K | SEC EDGAR | -4.41% | -4.20% | |
| Long Island Capital Alliance Appoints Kyle Lawrence to Board of Directors | Press release | ACCESS Newswire | -0.32% | +0.00% | |
| Applied DNA Announces Retirement of Chairperson and CEO Dr. James A. Hayward | Press release | ACCESS Newswire | +0.00% | +3.05% | |
| Form 8-K APPLIED DNA SCIENCES For: Jun 16 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +3.05% | |
| Applied DNA to Resume Quarterly Investor Call Cadence Beginning with FQ3'25 Financial Results Report in Mid-August | Press release | ACCESS Newswire | +2.75% | +8.94% | |
| Long Island Capital Alliance to Host Cannabis Capital Forum Featuring Top Industry Leaders and Investors | Press release | ACCESS Newswire | +0.00% | +8.56% | |
| Form 8-K APPLIED DNA SCIENCES For: May 30 | SEC filing · Form 8-K | SEC EDGAR | -1.67% | -3.94% | |
| Applied DNA Announces 1-For-15 Reverse Stock Split Effective June 2, 2025 | Press release | ACCESS Newswire | -2.60% | -18.40% | |
| Applied DNA Reschedules Intra-Quarter Webcast and Investor Update Call to June 17 | Press release | ACCESS Newswire | +0.17% | -3.27% | |
| Form 8-K APPLIED DNA SCIENCES For: May 29 | SEC filing · Form 8-K | SEC EDGAR | -2.60% | -18.40% | |
| Form 8-K APPLIED DNA SCIENCES For: May 22 | SEC filing · Form 8-K | SEC EDGAR | -0.02% | +4.63% | |
| Applied DNA Reports Second Quarter Fiscal 2025 Financial Results | Press release | ACCESS Newswire | -2.60% | -16.87% | |
| Form 10-Q APPLIED DNA SCIENCES For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | -2.60% | -16.87% | |
| Form 8-K APPLIED DNA SCIENCES For: May 15 | SEC filing · Form 8-K | SEC EDGAR | -2.60% | -16.87% | |
| Applied DNA to Announce Second Quarter Fiscal 2025 Financial Results on May 15, Schedules Intra-Quarter Investor Update Call for June 3 | Press release | ACCESS Newswire | — | +5.58% | |
| Applied DNA's LineaRx Subsidiary Stands Ready to Support the Reshoring of Drug Development and Manufacturing with U.S.-Produced Synthetic DNA | Press release | ACCESS Newswire | +0.28% | +0.15% | |
| Form DEF 14A APPLIED DNA SCIENCES For: May 22 | SEC filing · Form DEF | SEC EDGAR | -1.04% | -4.84% | |
| Applied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement | Press release | ACCESS Newswire | +2.39% | -18.12% | |
| Form 8-K APPLIED DNA SCIENCES For: Apr 07 | SEC filing · Form 8-K | SEC EDGAR | +2.39% | -18.12% | |
| Form PRE 14A APPLIED DNA SCIENCES For: May 22 | SEC filing · Form PRE | SEC EDGAR | +0.88% | +14.04% | |
| Applied DNA Positions TR8 PGx Testing Service as Pre-Emptive Testing for Safety of Fluoropyrimidine-Based Cancer Therapeutics Following Publication of Food and Drug Administration Safety Announcement | Press release | ACCESS Newswire | +6.83% | -0.30% | |
| Form 8-K APPLIED DNA SCIENCES For: Mar 30 | SEC filing · Form 8-K | SEC EDGAR | -0.60% | -4.76% | |
| Applied DNA Submits Validation Package to New York State Department of Health for H5 Bird Flu/Pan-Influenza A Laboratory-Developed Test | Press release | ACCESS Newswire | +0.47% | -4.19% | |
| Applied DNA Announces 1-For-50 Reverse Stock Split Effective March 14, 2025 | Press release | ACCESS Newswire | -1.63% | -35.20% | |
| Form 8-K APPLIED DNA SCIENCES For: Mar 12 | SEC filing · Form 8-K | SEC EDGAR | -1.82% | -17.21% | |
| Form 8-K APPLIED DNA SCIENCES For: Feb 28 | SEC filing · Form 8-K | SEC EDGAR | +0.42% | -2.94% | |
| Form 8-K APPLIED DNA SCIENCES For: Feb 14 | SEC filing · Form 8-K | SEC EDGAR | -1.13% | -0.83% | |
| Applied DNA Reports First Quarter Fiscal 2025 Financial Results and Highlights Operational Progress | Press release | ACCESS Newswire | +1.51% | -1.22% | |
| Form 10-Q APPLIED DNA SCIENCES For: Dec 31 | SEC filing · Form 10-Q | SEC EDGAR | +1.51% | -1.22% | |
| Form 8-K APPLIED DNA SCIENCES For: Feb 13 | SEC filing · Form 8-K | SEC EDGAR | +1.51% | -1.22% | |
| Applied DNA to Report First Quarter Fiscal 2025 Financial Results After Market Close on Thursday, February 13, 2025 | Press release | ACCESS Newswire | +0.06% | +5.39% | |
| Applied DNA Reminds Shareholders to Vote Ahead of Special Meeting on February 14 | Press release | ACCESS Newswire | +0.59% | +7.34% | |
| Form DEFA14A APPLIED DNA SCIENCES | SEC filing · Form DEFA14A | SEC EDGAR | +0.59% | +7.34% | |
| Form 8-K APPLIED DNA SCIENCES For: Jan 24 | SEC filing · Form 8-K | SEC EDGAR | -3.36% | -1.85% | |
| Form 8-K APPLIED DNA SCIENCES For: Jan 23 | SEC filing · Form 8-K | SEC EDGAR | -3.46% | -7.20% | |
| Form EFFECT APPLIED DNA SCIENCES | SEC filing · Form EFFECT | SEC EDGAR | -0.53% | -4.25% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the APDN section they belong to.
Where else APDN is measured.
APDN earnings → · Analyst actions → · SEC filings →
Other Industrials names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Digital Ally, Inc. (DGLY) | 179 | 0.00% | 44% |
| AIRBORNE WIRELES NTWK (ABWN) | 176 | 0.00% | 39% |
| AIR CANADA INC VTG & VAR (ACDVF) | 175 | 0.00% | 46% |
| Iveda Solutions, Inc. (IVDA) | 175 | -0.01% | 45% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.
All Industrials names, measured the same way →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Applied DNA Sciences, Inc.'s median reaction calculated?
Every labeled APDN news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 176 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 31% of APDN's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does APDN's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.